FDA Approved: CYCLOSET — Original Application (Avvisto Therapeutics LLC)

View source ↗

Summary

FDA approved CYCLOSET (bromocriptine mesylate) via an original NDA from Avvisto Therapeutics LLC, for the treatment of adults with type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• CYCLOSET (BROMOCRIPTINE MESYLATE)

Snippet

ORIG AP for CYCLOSET (BROMOCRIPTINE MESYLATE)